Among the 10 largest biopharmaceutical companies in the Stoxx 600 health index, five have a majority of their total sales ...
Pharma marketers enter 2026 asking where DTC fits in the DTP era. | Pharma marketers enter 2026 asking where DTC fits in the ...
Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...
Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. | ...
The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.
Cybin is rebranding itself as Helus Pharma and moving its stock listing to Nasdaq from the New York Stock Exchange. The pharmaceutical company said Thursday that its stock will trade on Nasdaq under ...
A notable finding is that audiences are split on whether they see more pharma ads in 2025 compared to 2024. Nearly half of ...
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.
The Council and the Parliament have reached a deal on new rules to make the EU’s pharmaceutical sector fairer and more ...
San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...
DGFT's floor prices on select bulk drugs aim to curb Chinese dumping, support PLI-backed manufacturers and lift domestic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback